SA to take part in two more COVID-19 vaccine trials

SA to take part in two more COVID-19 vaccine trials

South Africa is consolidating its place in the race for a COVID-19 vaccine with its participation starting from next month in two new international trials of vaccine candidates. Adele Baleta reports.

Read More

IN-DEPTH: Vaginal ring ushers in new era in HIV prevention

IN-DEPTH: Vaginal ring ushers in new era in HIV prevention

A recent announcement about a vaginal ring to prevent HIV has AIDS activists and women’s sexual and reproductive health advocates excited. But where would this ring fit in South Africa’s HIV prevention programme? Amy Green investigates.

Read More

Breakthrough hepatitis C medicines remain in regulatory limbo

Breakthrough hepatitis C medicines remain in regulatory limbo

Over the last decade the treatment of hepatitis C, a virus that can infect and damage the liver, has been revolutionised by a new class of medicines called direct acting antivirals. Catherine Tomlinson investigates the regulatory obstacles that are limiting access to these breakthrough medicines in South Africa.

Read More

Opinion: Despite significant challenges, SAHPRA is on the right track

Opinion: Despite significant challenges, SAHPRA is on the right track

Recently the South African Health Products Regulatory Authority was criticised for not approving laboratory-based SARS-CoV-2 antibody tests. Spotlight Editor Marcus Low argues that despite the regulator’s capacity constraints, its flexible conservatism is something to be grateful for.

Read More

COVID-19: Marketing of tunnels continues, despite criticism from WHO and scientists

COVID-19: Marketing of tunnels continues, despite criticism from WHO and scientists

The spraying of sanitisers on people in special tunnels or booths in order to combat COVID-19 has been condemned by scientists and government as unnecessary and potentially harmful. Some manufacturers nevertheless continue to market these products. Elna Schütz investigates.

Read More

Op-ed: Why SECTION27 and TAC are involved in a court case about complementary medicines

Op-ed: Why SECTION27 and TAC are involved in a court case about complementary medicines

The Pretoria High Court this week heard a challenge to the regulation of complementary medicine in South Africa. Tendai Mafuma and Julia Chaskalson explains why the case is important and why SECTION27 and the TAC got involved.

Read More

Covid-19: In Depth Interview with Prof Lynn Morris, interim head of the NICD

Covid-19: In Depth Interview with Prof Lynn Morris, interim head of the NICD

Professor Lynn Morris interim director of the National Institute for Communicable Diseases (NICD) has a lifetime of experience fighting viruses. She has encountered HIV, Ebola, TB, Listeria, Klebsiella, a multitude of ‘lesser’ pathogens and now COVID-19. However, she thinks that COVID-19, the name given for the disease caused by SARS-CoV-2, presents one of the greatest challenges yet to both South Africa and the world.

Read More